CACYBP anticorps (AA 1-185)

N° du produit ABIN5540232

L’anticorps anti-CACYBP Monoclonal Souris est utilisé pour la détection de CACYBP dans des échantillons de Humain. Il a été validé pour WB et EIA.

Aperçu rapide pour CACYBP anticorps (AA 1-185) (ABIN5540232)

Antigène: CACYBP (Calcyclin Binding Protein (CACYBP))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp CACYBP est non-conjugé

Application: Western Blotting (WB), Enzyme Immunoassay (EIA)

Clone: AT3G8

Détail du produit anti-CACYBP anticorps

Épitope: AA 1-185

Purification: Protein-A affinity chromatography

Immunogène: Recombinant human CACYBP (1-185aa) purified from E. coli.

Isotype: IgG2a

Information d'application

Indications d'application: The antibody has been tested by ELISA, Western blot analysis to assure specificity and reactivity. Since application varies, however, each investigation should be titrated by the reagent to obtain optimal results. Recommended starting dilution is 1:1000

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS, pH 7.4 containing 0.02 % Sodium Azide and 10 % Glycerol

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store undiluted at 2-8°C for up to two weeks or (in aliquots) at -20°C for longer. Avoid repeated freezing and thawing. Shelf life: one year from despatch.

Date de péremption: 12 months

Détails sur CACYBP

Antigène: CACYBP (Calcyclin Binding Protein (CACYBP))

Autre désignation: cacybp

Sujet: CACYBP (Calcyclin-binding protein) is primarily a nuclear protein that contains one CS domain and one SGS domain. CACYBP is believed to be involved in calcium-dependent ubiquitination and subsequent proteosomal degradation of target proteins. It most likely serves as a molecular bridge in ubiquitin E3 complexes. It also participates in the ubiquitin-mediated degradation of b-catenin. CACYBP is thought to be a potential inhibitor of cell growth and invasion in the gastric cancer cell through its effects on b-catenin protein expression and transcriptional activation of TCF/LEF.

UniProt: Q9HB71

Pathways: Response to Growth Hormone Stimulus